Discounting in Economic Evaluations

Arthur E Attema; Werner B. F. Brouwer; Karl Claxton

doi:10.1007/s40273-018-0672-z

Discounting in Economic Evaluations

Arthur E Attema, Werner B. F. Brouwer, Karl Claxton

Economics

Research output: Contribution to journal › Review article › peer-review

Abstract

Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda.

Original language	English
Journal	PharmacoEconomics
DOIs	https://doi.org/10.1007/s40273-018-0672-z
Publication status	E-pub ahead of print - 19 May 2018

Bibliographical note

Keywords

Journal Article
Review

Access to Document

10.1007/s40273-018-0672-z

Discounting in Economic Evaluations
© The Authors, 2018
Final published version, 528 KBLicence: CC BY

Cite this

@article{3184e4f9305a4a0b972f33f6c603378b,

title = "Discounting in Economic Evaluations",

abstract = "Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda.",

keywords = "Journal Article, Review",

author = "Attema, {Arthur E} and Brouwer, {Werner B. F.} and Karl Claxton",

note = "{\textcopyright} The Authors, 2018",

year = "2018",

month = may,

day = "19",

doi = "10.1007/s40273-018-0672-z",

language = "English",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Discounting in Economic Evaluations

AU - Attema, Arthur E

AU - Brouwer, Werner B. F.

AU - Claxton, Karl

PY - 2018/5/19

Y1 - 2018/5/19

N2 - Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda.

AB - Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda.

KW - Journal Article

KW - Review

U2 - 10.1007/s40273-018-0672-z

DO - 10.1007/s40273-018-0672-z

M3 - Review article

C2 - 29779120

SN - 1170-7690

JO - PharmacoEconomics

JF - PharmacoEconomics

ER -